OICR (Anthracycline sensitivity diagnostic)

oicr.on.ca
Innovation Type:
Diagnostics
Cancer Type:
Breast
Funding Stage:
Proof of Concept
Fund:
Prospects
Molecular profiling for anthracycline sensitivity - A novel diagnostic gene test with a high degree of accuracy, to predict whether a patient would benefit from Anthracycline chemotherapy treatment for breast cancer.

Related news

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.